A research team from LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has developed thyroid hormone (TH)–encapsulated nanoparticles modified with an adipose-homing peptide, which selectively transports TH to adipose tissues. This will advance the treatment of obesity-related medical complications with TH by overcoming the severe adverse effects caused by systemic administration. The new findings are now published in Nature Communications.
Click here for original story, Nanoparticle-based targeted drug delivery system for treatment of obesity and atherosclerosis
Source: Phys.org